Charleston, SC -- (SBWIRE) -- 09/11/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Prospect Global Resources Inc (NASDAQ:PGRX), PMC-Sierra Inc (NASDAQ:PMCS), Vical Incorporated (NASDAQ:VICL), Generex Biotechnology Corporation (OTCMKTS:GNBT).
Prospect Global Resources Inc (NASDAQ:PGRX) opened its last trade at the price of $4.58. Its closing price was $5.38 after gaining 23.68% for the day. The company traded with the total volume of 1,389,700 shares, while its average trading volume remained 137,702.00 shares. The beta of this stock stands at -11.10. Prospect Global Resources, Inc., a development stage company, engages in the exploration, development, and mining of natural resources and related fertilizer materials and products in the United States.
For How Long PGRX will Fight for Profitability? Read This Trend Analysis report
PMC-Sierra Inc (NASDAQ:PMCS) percentage change surged 2.32% to close at $6.62 with the total traded volume of 1,383,560 million shares, along with average volume of 2.05 million. The 52 week range of the stock remained $4.63 - $7.14, while its day lowest price was $6.487. The share price hit the day highest price of $6.65. PMC-Sierra, Inc. designs, develops, markets, and supports semiconductor solutions for communications network infrastructure in North America, Europe, and Asia.
For How Long PMCS’s Gloss will Attract Investors? Find out via this report
Vical Incorporated (NASDAQ:VICL) traded on volume of 1,375,170 shares in the last session against average volume of 3.36 million shares. The company started its trading session with the price of $1.24 and closed at $1.23 by scoring -0.81%. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Why Should Investors Buy VICL After the Recent Fall? Just Go Here and Find Out
Generex Biotechnology Corporation (OTCMKTS:GNBT) started its last trading session with the price of $0.03and closed at $0.0320 by scoring +1.59%. The stock traded with total volume of 1.36 million shares, while the average trading volume remained 2.46 million shares. The beta value of this stock stands at 1.90. Day range for the stock was $0.03 -$0.03. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After The Recent Gain? Just Go Here and Find Out
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)